BRIEF-Pharming Group enters into collaboration with Clinigen Group

Mon May 18, 2015 1:20am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

May 18 (Reuters) - Pharming Group NV :

* Enters into an international global access collaboration with Clinigen Group for HAEi

* HAEi GAP program will provide access to RUCONEST (Conestat Alfa) to eligible patients with hereditary angioedema (HAE)

Source text for Eikon: Further company coverage: (Gdynia Newsroom)